Enrichment of Allelic Editing Outcomes by Prime Editing in Induced Pluripotent Stem Cells
The CRISPR Journal · 01.10.2024 · 7 (5) · 293-304
DOI: 10.1089/crispr.2024.0028 ↗Kurz gefasst
Fachartikel in der Zeitschrift The CRISPR Journal, online erschienen am 18.10.2024. Verfasst von Ryo Niwa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Gene Editing, CRISPR-Cas Systems, Alleles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gene editing in human induced pluripotent stem (iPS) cells with programmable nucleases facilitates reliable disease models, but methods using double-strand break repair often produce random on-target by-products. Prime editing (PE) combines Cas9 nickase with reverse transcriptase and PE guide RNA (pegRNA) encoding a repair template to reduce by-products. We implemented a GMP-compatible protocol for transfecting Cas9- or PE-2A-mCherry plasmids to track and fractionate human iPS cells based on PE expression level. We compared the editing outcomes of Cas9- and PE-based methods in a GFP-to-BFP conversion assay at the HEK3 benchmark locus and at the APOE Alzheimer’s risk locus, revealing superior precision of PE at high expression levels. Moreover, sorting cells for PE expression level influenced allelic editing outcomes at the target loci. We expect that our findings will aid in the creation of gene-edited human iPS cells with intentional heterozygous and homozygous genotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
- Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- iPSC-Based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Kyoto, Japan.
- Medical-Risk Avoidance Based On iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Kyoto, Japan.
- MaxCyte Inc., Rockville, Maryland, USA.
ORCID-Profile: Ryo Niwa
Zitieren
APA
Niwa, R., Matsumoto, T., Liu, A. Y., Kawato, M., Kondo, T., Tsukita, K., Gee, P., Inoue, H., Maurissen, T. L., & Woltjen, K. (2024). Enrichment of Allelic Editing Outcomes by Prime Editing in Induced Pluripotent Stem Cells. The CRISPR Journal, 7(5), 293-304. https://doi.org/10.1089/crispr.2024.0028
Vancouver
Niwa R, Matsumoto T, Liu AY, Kawato M, Kondo T, Tsukita K, et al. Enrichment of Allelic Editing Outcomes by Prime Editing in Induced Pluripotent Stem Cells. The CRISPR Journal. 2024;7(5):293-304. doi:10.1089/crispr.2024.0028
BibTeX
@article{Niwa2024,
author = {Niwa, Ryo and Matsumoto, Tomoko and Liu, Alexander Y and Kawato, Maki and Kondo, Takayuki and Tsukita, Kayoko and Gee, Peter and Inoue, Haruhisa and Maurissen, Thomas L and Woltjen, Knut},
title = {Enrichment of Allelic Editing Outcomes by Prime Editing in Induced Pluripotent Stem Cells},
journal = {The CRISPR Journal},
year = {2024},
volume = {7},
number = {5},
pages = {293--304},
doi = {10.1089/crispr.2024.0028}
}
EUVIMED